Brain pacemaker offers hope for severe OCD

NCT ID NCT02773082

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a device called Reclaim DBS, which uses electrical pulses to target brain areas linked to OCD. It's for adults with severe, treatment-resistant OCD who have tried at least three medications and therapy. The goal is to see if it safely reduces obsessive-compulsive symptoms.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
deep brain stimulation device
What this could lead to
If successful, this could offer a new, reversible option for people with severe OCD who haven't responded to other treatments.
What could go wrong
This is an early-stage study with only 50 participants. Risks include infection, bleeding, and that the device may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSESSIVE COMPULSIVE DISORDER (OCD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Zucker Hillside Hospital

    RECRUITING

    Queens, New York, 11004, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.